Rivernorth Capital Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Rivernorth Capital Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-118,662	Closed	-$31K	–	387
2020 Q3	$31K	Hold	118,662	–	–	﹤0.01%	325
2020 Q2	$53K	Sell	118,662 -1,337	-1%	-$201	﹤0.01%	250
2020 Q1	$8K	Hold	119,999	–	–	﹤0.01%	269
2019 Q4	$21K	Hold	119,999	–	–	﹤0.01%	255
2019 Q3	$20K	Hold	119,999	–	–	0.09%	34
2019 Q2	$26	Hold	119,999	–	–	﹤0.01%	232
2019 Q1	$22K	Hold	119,999	–	–	﹤0.01%	226
2018 Q4	$36K	Hold	119,999	–	–	﹤0.01%	273
2018 Q3	$54K	Buy	119,999 +29,958	+33%	+$13.6K	﹤0.01%	192
2018 Q2	$34K	Buy	+90,041	New	+$41.2K	﹤0.01%	206

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

Rivernorth Capital Management's NRXPW Position: Q4 2020 in Review

Rivernorth Capital Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 118,662 shares — an estimated $31K sold.

Rivernorth Capital Management first reported a position in NRXPW in Q2 2018 and held it in 10 quarters. The position peaked at $54K in Q3 2018. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

Rivernorth Capital Management reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
Rivernorth Capital Management sold 118,662 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $31K.
Rivernorth Capital Management first reported a position in NRX Pharmaceuticals Warrant in Q2 2018 and held it in 10 quarters.
Rivernorth Capital Management's NRX Pharmaceuticals Warrant position peaked at $54K in Q3 2018.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on Rivernorth Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.